Abstract
Adenomyosis is due to the invasion or presence of endometrial glands in the uterine myometrium accompanied by hyperplasia and hypertrophy of the surrounding muscle cells, forming diffuse or focal lesions. Adenomyosis occurs most often in women between the ages of 30 and 50, but it can also be in younger women who have not had children. The incidence of adenomyosis is about 20–30% of reproductive-aged women, but this varies according to the particular population [1]. Recently, there appears to have a significant increase in the incidence and younger age patients. Thirty-five percent of patients are without symptoms, 15–30% associated with pelvic endometriosis, and 50% with uterine fibroids. The pathogenesis of adenomyosis is unknown, but in some patients, there is a belief that any intrauterine manipulations such as surgical termination of pregnancy can damage the endometrium’s basal layer, causing the endometrial gland to invade into the myometrium thus increasing the extent and severity of adenomyosis. Adenomyosis can then lead to dysmenorrhea and increased menstrual flow, infertility, and other related symptoms [2]. This disease seriously affects women’s physical and mental health.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Naftalin J, et al. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012;27(12):3432–9.
Peric H, Fraser I. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):547–55.
Bernardi M, et al. Dysmenorrhea and related disorders. F1000 Res. 2017;6:1645.
Zhou J, et al. Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: a long-term follow-up study of 252 cases. PLoS One. 2016;11(11):e0165610.
Takeda J, et al. Spontaneous uterine rupture at 32 weeks of gestation after previous uterine artery embolization. J Obstet Gynaecol Res. 2014;40(1):243–6.
Homer H, Saridogan E. Pregnancy outcomes after uterine artery embolisation for fibroids. Obstet Gynaecol. 2009;11(4):265–70.
Zhou C, Xu X, He J. Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation. Zhonghua Fu Chan Ke Za Zhi. 2016;51(11):845–9.
Chen J, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–6.
Zhou M, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011;95(3):900–5.
Zhang X, et al. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound. Int J Gynecol Obstet. 2014;124(3):207–11.
Shui L, et al. High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results. Ultrason Sonochem. 2015;27:677–81.
Feng Y, et al. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: a retrospective cohort study. Ultrason Sonochem. 2017;36:139–45.
Guo Y, et al. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study. BJOG Int J Obstet Gynaecol. 2017;124(S3):7–11.
Yang X, et al. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis. Int J Hyperth. 2019;36(1):485–91.
Gong C, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int J Hyperth. 2016;32(5):496–503.
Liu X, et al. Clinical predictors of long-term success in ultrasound-guided high-intensity focused ultrasound ablation treatment for adenomyosis: a retrospective study. Medicine. 2016;95(3):e2443.
Ye M, et al. Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis. Zhonghua Fu Chan Ke Za Zhi. 2016;51(9):643–9.
Cheung VY. Current status of high-intensity focused ultrasound for the management of uterine adenomyosis. Ultrasonography. 2017;36(2):95.
Wu Ziyu PZ, Xiuping L, Yueyue D, Mingjie J. Clinical observation of high-intensity focused ultrasound in combination with LNG-IUS treatment of uterine adenomyosis. Shandong Med. 2018;58(3):65–7.
Ye Mingzhu DX, Xiaogang Z, Min X. High-intensity focused ultrasound ablation techniques combined with of GnRH-a and LNG-IUS in the treatment of uterine adenomyosis. Chin J Obstet Gynecol. 2016.
Haiyan S, et al. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up. Int J Hyperth. 2019;36(1):1179–85.
Campo S, Campo V, Benagiano G. Adenomyosis and infertility. Reprod Biomed Online. 2012;24(1):35–46.
Rabinovici J, et al. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod. 2006;21(5):1255–9.
Kim KA, et al. Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction. Fertil Steril. 2011;95(3):1152–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wong, F., Zhang, L., Wang, Z. (2021). Adenomyosis and HIFU Ablation. In: Focused Ultrasound Surgery in Gynecology. Springer, Singapore. https://doi.org/10.1007/978-981-16-0939-8_5
Download citation
DOI: https://doi.org/10.1007/978-981-16-0939-8_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-0938-1
Online ISBN: 978-981-16-0939-8
eBook Packages: MedicineMedicine (R0)